Lv1
74 积分 2025-11-06 加入
Abdeg technology for the treatment of myasthenia gravis: efgartigimod drug experience
11小时前
已完结
Sweeping antibody as a novel therapeutic antibody modality capable of eliminating soluble antigens from circulation
3天前
已完结
Research progress and development strategies of antibody-oligonucleotide conjugates
18天前
已完结
Expanding RNAi therapeutics to extrahepatic tissues with lipophilic conjugates
20天前
已完结
Targeting the transferrin receptor to transport antisense oligonucleotides across the mammalian blood-brain barrier
1个月前
已完结
DNA-Encoded Antibody Libraries: A Unified Platform for Multiplexed Cell Sorting and Detection of Genes and Proteins
1个月前
已完结
Antibody humanization by redesign of complementarity-determining region residues proximate to the acceptor framework
1个月前
已完结
Characterization and elimination of artificial non-covalent light Chain dimers in reduced CE-SDS analysis of pertuzumab
1个月前
已完结
Can multispecific biologics break the efficacy ceiling?
1个月前
已完结
Multispecific T-cell engagers attract cancer drug developers
1个月前
已完结
皖公网安备34019202002308
